STANDARD BIOTOOLS INC. - COMMON STOCK

Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

01 Apr 2022 13:05:00 By Nasdaq GlobeNewswire

Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

29 Mar 2022 06:29:06 By Nasdaq GlobeNewswire

Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

28 Mar 2022 05:30:00 By Nasdaq GlobeNewswire

Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

25 Mar 2022 13:00:00 By Nasdaq GlobeNewswire

Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

21 Mar 2022 05:00:01 By Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

17 Mar 2022 14:58:32 By Nasdaq GlobeNewswire

Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 

17 Feb 2022 14:43:00 By Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

17 Feb 2022 05:30:01 By Nasdaq GlobeNewswire

Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

14 Feb 2022 03:10:00 By Nasdaq GlobeNewswire

Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.

24 Jan 2022 05:30:01 By Nasdaq GlobeNewswire

Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021

11 Jan 2022 05:00:01 By Nasdaq GlobeNewswire

Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19

07 Dec 2021 05:30:00 By Nasdaq GlobeNewswire

Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

16 Nov 2021 05:30:00 By Nasdaq GlobeNewswire

Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost

11 Nov 2021 05:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces Third Quarter 2021 Financial Results

08 Nov 2021 13:02:00 By Nasdaq GlobeNewswire

Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer

08 Nov 2021 05:30:01 By Nasdaq GlobeNewswire

Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results

20 Oct 2021 05:30:00 By Nasdaq GlobeNewswire

Fluidigm 2021 IMC Summit Focuses on ‘Uncovering Spatial Biology’

18 Oct 2021 05:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software

12 Oct 2021 05:30:00 By Nasdaq GlobeNewswire

Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT

28 Sep 2021 05:30:00 By Nasdaq GlobeNewswire